Physician profile
Mark Dudash
NPI 1124477617
$19,265.83
in general payments reported to CMS, 2019-2025
14 companies · $9,618 in 2025
The $9,618 reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $86.49 · 2023: $1,813 · 2024: $7,749 · 2025: $9,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Travel and Lodging: $3,942 · Food and Beverage: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,197.59 |
| Travel and Lodging | $3,942.12 |
| Food and Beverage | $2,039.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,603.44 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Teleflex LLC | $583.40 | 2024-2025 | Titan Sgs Bailout Chuck, Titan Sgs, Manta |
| Medtronic, INC. | $571.30 | 2025 | Progrip, Transorb |
| Boston Scientific Corporation | $155.40 | 2022-2023 | Resolution 360 Clip |
| Tela Bio, INC. | $141.78 | 2024 | Ovitex 2s |
| Janssen Biotech, INC. | $43.00 | 2022-2023 | Stelara |
| Smith+Nephew, INC. | $33.40 | 2023 | Pico |
| Cardiva Medical, INC. | $28.13 | 2023 | Cardiva Vascade 6/7f Vcs |
| Avita Medical Americas, LLC | $21.83 | 2024 | |
| Integra Lifesciences Corporation | $18.09 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Takeda Pharmaceuticals U.S.A., INC. | $17.79 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.69 | 2023 | Xifaxan |
| Olympus America INC. | $16.10 | 2025 | 4k Cable 3.0m |
| Baxter Healthcare | $14.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dudash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.